Lluís Castells Selected Research

Lluís Castells Research Topics

13	Infections 01/2022 - 10/2002
8	Fibrosis (Cirrhosis) 01/2018 - 01/2003
6	COVID-19 01/2022 - 01/2021
6	Liver Diseases (Liver Disease) 01/2018 - 04/2011
6	Hepatitis C 01/2018 - 02/2006
4	Chronic Hepatitis C 01/2018 - 04/2016
3	End Stage Liver Disease 06/2020 - 02/2006
3	Hepatocellular Carcinoma (Hepatoma) 06/2018 - 04/2015
3	Hepatitis B 04/2011 - 10/2002
2	Hepatic Encephalopathy 05/2022 - 01/2003
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 02/2012
2	Bacterial Infections (Bacterial Infection) 03/2021 - 01/2020
2	Peritonitis 03/2021 - 07/2014
2	Hepatitis 01/2020 - 05/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 08/2008
1	Mycoses (Diseases, Fungus) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Bacteremia 03/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020
1	Autoimmune Hepatitis 01/2020
1	Virus Diseases (Viral Diseases) 01/2017
1	Renal Insufficiency (Renal Failure) 10/2014
1	HIV Infections (HIV Infection) 01/2014
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2009
1	Visceral Leishmaniasis (Kala Azar) 12/2008
1	Ascites 08/2008
1	Brain Diseases (Brain Disorder) 08/2008
1	Metabolic Diseases (Metabolic Disease) 08/2008
1	Hyponatremia 08/2008
1	Cytomegalovirus Infections (Inclusion Disease) 07/2005
1	Reinfection 07/2005
1	Liver Failure 10/2002

7	Antiviral Agents (Antivirals)IBA 01/2018 - 07/2005
5	Immunoglobulin G (IgG)IBA 01/2022 - 01/2014
4	SofosbuvirIBA 01/2018 - 05/2015
4	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 07/2005
3	AntibodiesIBA 01/2022 - 01/2021
3	daclatasvirIBA 10/2017 - 04/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 01/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 07/2005
2	InterferonsIBA 01/2017 - 07/2005
2	Cytidine Triphosphate (CTP)IBA 01/2017 - 04/2016
2	Immunoglobulins (Immunoglobulin)IBA 04/2011 - 02/2006
2	DNA (Deoxyribonucleic Acid)IBA 04/2011 - 10/2002
1	TriazolesIBA 01/2022
1	isavuconazoleIBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	TabletsIBA 01/2018
1	velpatasvirIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 04/2016
1	SimeprevirIBA 04/2016
1	RNA (Ribonucleic Acid)IBA 04/2016
1	Sorafenib (BAY 43-9006)FDA Link 04/2015
1	Third Generation CephalosporinsIBA 07/2014
1	Formaldehyde (Formol)FDA Link 08/2013
1	AntigensIBA 08/2013
1	ParaffinIBA 08/2013
1	hepatitis B hyperimmune globulinIBA 04/2011
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 03/2009
1	Rifaximin (L 105)FDA Link 01/2003
1	lactitolIBA 01/2003
1	Lamivudine (Epivir)FDA Link 10/2002
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2002

27	Liver Transplantation 05/2022 - 10/2002
9	Transplantation 01/2022 - 01/2014
5	Therapeutics 01/2021 - 10/2002
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2022 - 02/2012
2	Organ Transplantation 01/2021 - 01/2021
2	Kidney Transplantation 06/2018 - 06/2018
2	Aftercare (After-Treatment) 01/2018 - 01/2017
1	Catheters 03/2021
1	Blood Transfusion (Blood Transfusions) 06/2020